Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated May 14, 2021, titled "SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of PDP-716 for the Treatment of Open Angle Glaucoma or Ocular Hypertension".